Penicillin redux: Rearming proven warriors for the 21st century

April 14, 2014 by Steven Powell
Conjugates of a beta-lactam antibiotic with the team's metallopolymer had enhanced antimicrobial properties compared with the antibiotic alone. The effect was particularly striking with hospital-associated MRSA (left). Credit: Journal of the American Chemical Society

Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called "superbugs."

Bacteria have been chipping away at the power of the penicillin family of drugs since their first wide-scale use as in the 1940s. For example, the staph infection, brought about by the bacterium Staphylococcus aureus, was once readily treated with penicillin and its molecular cousins.

But that bug has changed. In the 1960s, a new strain arrived, termed MRSA for methicillin- (or sometimes multidrug-) resistant S. aureus. It has become a serious problem because the earliest deployed antibiotics are often useless against the new strain, and its prevalence has only increased since it was first observed. MRSA (pronounced mer-suh) is sometimes called a superbug because of the difficulty physicians have in treating infected patients.

The S. aureus microbe has evolved the MRSA strain by developing a variety of defenses against antibiotics to which they've been exposed. One of those defenses effectively neutralizes penicillin's greatest strength.

That strength is its molecular core, a cyclic four-membered amide ring termed a beta-lactam. It is a common structural element of the penicillins, their synthetic and semi-synthetic derivatives, and other related molecules that constitute the broad family of drugs called the beta-lactam antibiotics. Just a few examples (of dozens) include amoxicillin, ampicillin and cefazolin.

The beta-lactam structure in a molecule is something that many bacteria don't like at all. It greatly hinders their ability to reproduce by cell division, and so chemists have for years spent time making molecules that all contain the beta-lactam structural motif, but differ in the surrounding molecular "shrubbery." Physicians heavily use the many versions of beta-lactam antibiotics to fight bacterial infections, and many have been retired because they're no longer effective against the defenses bacteria have evolved in response.

One of the most effective bacterial defenses is an enzyme called beta-lactamase, which chews up the beta-lactam structure. Some bacteria, such as MRSA, have developed the ability to biosynthesize and release beta-lactamase when needed. It's a devastating defense because it's so general, targeting the common structural motif in all of the many beta-lactam antibiotics.

But that also creates the opportunity for a general approach to solving the problem, which is what Carolina's Chuanbing Tang and colleagues just reported in the Journal of the American Chemical Society.

"Instead of developing , here we ask the question, 'can we recycle the old antibiotics?' " he said. "With traditional antibiotics like G, amoxicillin, ampicillin and so on, can we give them new life?"

The approach pairs the drug with a protective polymer developed in Tang's chemistry laboratory. In lab tests, graduate student Jiuyang Zhang prepared a cobaltocenium metallopolymer that greatly slowed the destructiveness of beta-lactamase on a model beta-lactam molecule (nitrocefin).

The interdisciplinary team, which included Mitzi Nagarkatti and Alan Decho, from the university's School of Medicine and Arnold School of Public Health, respectively, also showed that the antimicrobial effectiveness of the four beta-lactams studied in detail was enhanced by the polymer. The enhancement was modest against two strains, but very pronounced with the hospital-associated strain of MRSA (HA-MRSA).

The metallopolymer by itself even demonstrated antimicrobial properties, lysing bacterial cells while leaving human red blood cells unaffected. By a variety of measures, the polymer was found to be nontoxic to human cells in laboratory tests.

The project is still far from clinical use, but Tang knows moving forward is imperative.

"In the United States every year, around 100,000 patients die of bacteria-induced infections," Tang said. "And the problem is increasing because bacteria are building resistance.

"It's a really, really big problem, not only for individual patients, but also for society."

Explore further: Decoding the proteins behind drug-resistant superbugs

More information: Paper: dx.doi.org/10.1021/ja5011338

Related Stories

Decoding the proteins behind drug-resistant superbugs

September 16, 2011

Penicillin and its descendants once ruled supreme over bacteria. Then the bugs got stronger, and hospitals have reported bacterial infections so virulent that even powerful antibiotics held in reserve for these cases don't ...

Researchers uncover keys to antibiotic resistance in MRSA

October 4, 2013

(Phys.org) —University of Notre Dame researchers Shahriar Mobashery and Mayland Chang and their collaborators in Spain have published research results this week that show how methicillin-resistant Staphylococcus aureus ...

Chemists discover new class of antibiotics

March 7, 2014

(Phys.org) —A team of University of Notre Dame researchers led by Mayland Chang and Shahriar Mobashery have discovered a new class of antibiotics to fight bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) ...

Recommended for you

Findings illuminate animal evolution in protein function

July 27, 2015

Virginia Commonwealth University and University of Richmond researchers recently teamed up to explore the inner workings of cells and shed light on the 400–600 million years of evolution between humans and early animals ...

New polymer able to store energy at higher temperatures

July 30, 2015

(Phys.org)—A team of researchers at the Pennsylvania State University has created a new polymer that is able to store energy at higher temperatures than conventional polymers without breaking down. In their paper published ...

How to look for a few good catalysts

July 30, 2015

Two key physical phenomena take place at the surfaces of materials: catalysis and wetting. A catalyst enhances the rate of chemical reactions; wetting refers to how liquids spread across a surface.

Yarn from slaughterhouse waste

July 29, 2015

ETH researchers have developed a yarn from ordinary gelatine that has good qualities similar to those of merino wool fibers. Now they are working on making the yarn even more water resistant.

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Nik_2213
not rated yet Apr 14, 2014
Hopefully, a cocktail of beta-lactamase inhibitors will have a synergic effect...
DonGateley
not rated yet Apr 15, 2014
How can you work on these things and not believe your foe to be intelligent. I know, I know but there are several things I know for certain aren't true that I can't help believing anyway so I just humor my believer.
alfie_null
not rated yet Apr 15, 2014
Should this technique be found effective, I'd bet just as with existing antibiotics, a major use will be with livestock, so we can raise livestock in ever more filthy conditions.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.